Lysosomal Therapeutics Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Following Divestments, AMAG Fetches Net

Avalon Ventures managing director Jay Lichter said it was surprising when Merck & Co. Inc. was one of the first and most aggressive pursuers of the venture capital firm’s Calporta Therapeutics Inc.

IN VITRO DIAGNOSTICS Mergers & Acquisitions PerkinElmer Inc. Tulip Diagnostics Pvt. Ltd. PerkinElmer Inc. is acquiring Indian firm Tulip Diagnostics Pvt. Ltd. (Jan.) Tulip focuses on assay sys

Gilead Can Expect Another Series Of Queries On M&A Strategy With its hepatitis C franchise slowing down and HIV not fully offsetting that, Gilead Sciences Inc. likely will face another litany of q